ClearArc Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-12,629
| Closed | -$713K | – | 448 |
|
|
2015
Q3 | $713K | Sell |
12,629
-3,794
| -23% | -$214K | 0.15% | 180 |
|
|
2015
Q2 | $971K | Sell |
16,423
-22
| -0.1% | -$1.3K | 0.18% | 153 |
|
|
2015
Q1 | $1.03M | Sell |
16,445
-3,429
| -17% | -$214K | 0.21% | 137 |
|
|
2014
Q4 | $1.14M | Buy |
19,874
+2,206
| +12% | +$127K | 0.23% | 132 |
|
|
2014
Q3 | $950K | Buy |
17,668
+2,057
| +13% | +$111K | 0.21% | 139 |
|
|
2014
Q2 | $818K | Buy |
15,611
+544
| +4% | +$28.5K | 0.19% | 151 |
|
|
2014
Q1 | $796K | Sell |
15,067
-1,285
| -8% | -$67.9K | 0.2% | 146 |
|
|
2013
Q4 | $655K | Buy |
16,352
+2,851
| +21% | +$114K | 0.17% | 165 |
|
|
2013
Q3 | $510K | Buy |
13,501
+4,872
| +56% | +$184K | 0.14% | 179 |
|
|
2013
Q2 | $338K | Buy |
+8,629
| New | +$338K | 0.09% | 247 |
|